2006
DOI: 10.1590/s0104-42302006000600015
|View full text |Cite
|
Sign up to set email alerts
|

Leishmaniose tegumentar americana

Abstract: Homem, 68 anos, trabalhador rural, natural e procedente de Sabará/MG, foi atendido previamente pelo Serviço de Clínica Médica da Santa Casa de Sabará. Apresentava uma extensa úlcera na perna esquerda, indolor, de bordas bem definidas e moderada secreção purulenta, com início havia sete meses. Tabagista (20 cigarros/dia por 40 anos) e hipertenso (em uso de hidroclorotiazida 25 mg/dia). Negava diabetes e uso de outras medicações. Sem outras queixas. Ausculta cardíaca e pulmonar sem alterações. Abdome normal sem … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
3
0
2

Year Published

2011
2011
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 0 publications
0
3
0
2
Order By: Relevance
“…This disease presents manifestations ranging from the formation of the single ulcer to disseminated forms and can affect the mucous [1,2]. It consists of a Public Health problem, due to its high incidence, wide distribution and great complexity, with the possibility of the appearance of destructive, disfiguring and even incapacitating lesions for infected individuals [3,4]. Despite advances in parasite studies, as well as knowledge of the disease, therapies have now been based on the use of pentavalent antimonials such as sodium stibogluconate (Pentostam®) and antimoniate N-methyl-glucamine (Glucantime®), besides the use of amphotericin B or pentamidines, however they present difficulties of administration, high cost and important side effects [5][6][7].…”
Section: Introductionmentioning
confidence: 99%
“…This disease presents manifestations ranging from the formation of the single ulcer to disseminated forms and can affect the mucous [1,2]. It consists of a Public Health problem, due to its high incidence, wide distribution and great complexity, with the possibility of the appearance of destructive, disfiguring and even incapacitating lesions for infected individuals [3,4]. Despite advances in parasite studies, as well as knowledge of the disease, therapies have now been based on the use of pentavalent antimonials such as sodium stibogluconate (Pentostam®) and antimoniate N-methyl-glucamine (Glucantime®), besides the use of amphotericin B or pentamidines, however they present difficulties of administration, high cost and important side effects [5][6][7].…”
Section: Introductionmentioning
confidence: 99%
“…This variation has been associated with the patient's immunological status and with the species of Leishmania. 3,[11][12][13] This aspect of the infection makes clinical diagnosis difficult, and there needs to be a strong proof of suspicion of the disease.…”
Section: Introductionmentioning
confidence: 99%
“…(V.) braziliensis in Acre (Ávila et al, 2018), Rondônia (Grimaldi et al, 1991) and Pará (Souza et al 2010), Le. (L.) amazonensis in Amazonas and Rondônia (Resadore et al, 2019), besides being also considered one of the potential vectors of Leishmania (V.) naiffi in the Amazon region (Castellón et al, 1994;Gontijo and Carvalho, 2003;Gonçalves et al, 2016). This species has already been found as the most abundant in studies carried out in the Eastern Amazon (18.2%) (Pereira Júnior et al, 2019), in our study, it was the fifth most collected species (6.0%), and was found infected with DNA from Leishmania spp.…”
Section: Discussionmentioning
confidence: 99%